about
The human immunodeficiency virus tat protein increases the transcription of human Alu repeated sequences by increasing the activity of the cellular transcription factor TFIIICDetection of human immunodeficiency virus in cell-free seminal fluidGlycosylation and processing of the human immunodeficiency virus type 1 envelope proteinSulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of actionA phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcomaSelective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replicationPhosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4Preactivated merocyanine 540 inactivates HIV-1 and SIV: potential therapeutic and blood banking applicationsExacerbation of dideoxycytidine-induced neuropathy with dideoxyinosineExtended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosineExacerbation of human immunodeficiency virus infection in promonocytic cells by bacterial immunomodulatorsEnhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-gamma and reduced doses of trimethoprim/sulfamethoxazolePotentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine ribosideInterferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposureCastanospermine vs. its 6-O-butanoyl analog: a comparison of toxicity and antiviral activity in vitro and in vivoAntiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virusSynergistic anti-Pneumocystis carinii effects of erythromycin and sulfisoxazoleZidovudine therapy in an inner city populationInactivation of human immunodeficiency virus by Betadine products and chlorhexidineSelective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitroAntiviral agents with activity against human retrovirusesLow Education as a Possible Risk Factor for Cognitive Abnormalities in HIV-1Family physician attitudes about HIV screening.Preferential antibody recognition of structurally distinct HIV-1 gp120 molecules.A simple correction of AIDS surveillance data for reporting delays.The effect of tuberculosis as a new AIDS definition criterion in epidemiological surveillance data from a south European area.A simplified surveillance case definition of AIDS derived from empirical clinical data. The Clinical AIDS Study Group, and the Working Group on AIDS case definition.Comparison of AIDS and HIV antibody surveillance data in Colorado.A methodology for building an AIDS research file using Medicaid claims and administrative data bases.Absence of Mycobacterium avium complex disease in patients with AIDS in Uganda.HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities.Thrombocytopenia in children infected with human immunodeficiency virus: long-term follow-up and therapeutic considerations.Increasing impact of HIV infection on hospitalizations in the United States, 1983-1988.Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet.The effect of zidovudine on platelet count in HIV-infected individuals.In vivo analysis of castanospermine, a candidate antiretroviral agent.The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.Progression to AIDS or death following diagnosis with a class IV non-AIDS disease: utilization of a surveillance database.Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study.Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro.
P1433
Q28190831-AAA3EBB4-A313-4CCE-8BA0-1B4AF2305426Q28236261-1EF08F2F-A7CD-4F57-AEDC-144215C31BB2Q28269032-878C6C9F-8DE0-4D0B-AB37-25640D758F50Q28318643-3B904CF3-C804-4050-A15D-21ED317ED81BQ28322447-7F70696C-6DBE-44AC-9B53-DDE68D962BC2Q28322729-AAC8BF74-9552-4EBC-9463-F327E2F51216Q28323866-EEE690B4-444E-4B3C-B6D5-0471B2961A71Q28324445-92C3E502-D4C9-4A4A-9A1B-36E8AF648035Q28327056-B63747B5-12F5-4303-9023-7D6C89C12786Q28327344-75A8863B-CCB3-4E33-AE1F-7E9DD730A670Q28329191-2643B1B0-BF96-47B9-8D08-528A275D47BFQ28329548-A96FDDAF-E9EA-492D-AF93-FF82A2E13411Q28329682-2C459ECF-1E0F-40D5-BFC1-36C39B89788BQ28330415-2469ECC3-79C8-4AD6-81B2-9A5E0074E1F3Q28334567-80BA93EF-BA5A-49EB-8249-B6FD8F1A0BC0Q28335398-907D4771-8355-4849-A541-403A973D7245Q28335404-5258D770-E35F-4C11-99DF-E24DBB253983Q28335799-EBB97EAB-132A-43F9-B315-3FEB567CBB66Q28339500-D4AB9615-DFCA-4188-866C-137554A33C22Q28339822-C70224A3-9B2F-4AD0-8E56-2C1BA79856A4Q28340228-985CD32D-378C-4A1F-BA94-4ADA177CE006Q29540688-FA9ECD19-60B1-4057-B277-37CAA7E5E6A0Q30233908-3D1065B3-7F95-4450-BE65-06BE209BDBD6Q30416805-1BA869EF-CCEE-4169-A5C5-E5DF98AF0271Q30560175-0CDDE575-B71C-4009-A7F7-49E70167A76DQ30572184-9FC977E1-FCB0-4161-B1F7-F50BAF64A39AQ30881780-BEF3E0D6-80D4-444C-89A5-A02DC0D61E05Q31067180-CF1ED6F1-4DCE-4CC8-813F-7F20B805EBA8Q31148937-631FAE2A-9CCF-410F-AEBD-5BB865377140Q33209971-2E007806-5D93-4E90-810D-ABA0077284C6Q33285996-F14CC3F9-1947-4CC5-8299-282412AB62B7Q33364176-0803BC77-49FB-491F-8F64-8D867DC2C6B2Q33364178-6F51BDAB-B570-4929-9A39-BB50A843A7F4Q33379636-243CA88A-0866-45FD-8D24-08B4EB7F9351Q33396875-50A5E7E9-5CB3-4EC5-894B-BEBD4466A601Q33416049-88DC4032-E4C7-4660-8FA1-24E15192EA60Q33484423-8A3877A8-B967-483B-8951-729ED7BD0FBDQ33490847-AC204964-47C0-4B12-90B7-54F297AC1F56Q33492170-E8B2688B-60B1-48A2-987B-6E52709E34A6Q33590942-37302035-2A09-4720-BA55-935B1830CDEF
P1433
description
czasopismo naukowe
@pl
revista científica
@es
revue scientifique
@fr
scientific journal
@en
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
науковий журнал
@uk
name
Journal of Acquired Immune Deficiency Syndromes
@ast
Journal of Acquired Immune Deficiency Syndromes
@de
Journal of Acquired Immune Deficiency Syndromes
@en
Journal of Acquired Immune Deficiency Syndromes
@fr
Journal of Acquired Immune Deficiency Syndromes
@it
type
label
Journal of Acquired Immune Deficiency Syndromes
@ast
Journal of Acquired Immune Deficiency Syndromes
@de
Journal of Acquired Immune Deficiency Syndromes
@en
Journal of Acquired Immune Deficiency Syndromes
@fr
Journal of Acquired Immune Deficiency Syndromes
@it
altLabel
J Acquir Immune Defic Syndr
@en
J. Acquir. Immune Defic. Syndr.
@en
prefLabel
Journal of Acquired Immune Deficiency Syndromes
@ast
Journal of Acquired Immune Deficiency Syndromes
@de
Journal of Acquired Immune Deficiency Syndromes
@en
Journal of Acquired Immune Deficiency Syndromes
@fr
Journal of Acquired Immune Deficiency Syndromes
@it
P3181
P1055
P1156
P1476
Journal of Acquired Immune Deficiency Syndromes
@en